观点论文：靶向多种细胞周期蛋白依赖性激酶（CDK）：分子对接研究的新策略。 - Suppr

Opinion Paper: Targeting Multiple Cyclin-Dependent Kinases (CDKs): A New Strategy for Molecular Docking Studies.

作者信息

de Azevedo Walter Filgueira

机构信息

Faculty of Biosciences, Pontifical Catholic University of Rio Grande do Sul. Av. Ipiranga, 6681, Porto Alegre-RS, 90690-900 Brazil.

出版信息

Curr Drug Targets. 2016;17(1):2. doi: 10.2174/138945011701151217100907.

DOI:10.2174/138945011701151217100907

PMID:26687602

Abstract

摘要

相似文献

Opinion Paper: Targeting Multiple Cyclin-Dependent Kinases (CDKs): A New Strategy for Molecular Docking Studies.

Curr Drug Targets. 2016;17(1):2. doi: 10.2174/138945011701151217100907.

Targeting Cyclin-Dependent Kinases and Cell Cycle Progression in Human Cancers.

Semin Oncol. 2015 Dec;42(6):788-800. doi: 10.1053/j.seminoncol.2015.09.024. Epub 2015 Sep 24.

The roles and therapeutic potential of cyclin-dependent kinases (CDKs) in sarcoma.

Cancer Metastasis Rev. 2016 Jun;35(2):151-63. doi: 10.1007/s10555-015-9601-1.

Recent advances on CDK inhibitors: An insight by means of in silico methods.

Eur J Med Chem. 2017 Dec 15;142:300-315. doi: 10.1016/j.ejmech.2017.07.067. Epub 2017 Aug 4.

The anticancer activity of the substituted pyridone-annelated isoindigo (5'-Cl) involves G0/G1 cell cycle arrest and inactivation of CDKs in the promyelocytic leukemia cell line HL-60.

Cell Physiol Biochem. 2015;35(5):1943-57. doi: 10.1159/000374003. Epub 2015 Mar 27.

Clinical anticancer drug development: targeting the cyclin-dependent kinases.

Br J Cancer. 2005 Jan 17;92(1):7-12. doi: 10.1038/sj.bjc.6602229.

Tetrahydro-3H-pyrazolo[4,3-a]phenanthridine-based CDK inhibitor.

Chem Commun (Camb). 2018 May 1;54(36):4521-4524. doi: 10.1039/c8cc01154k.

Early development of cyclin dependent kinase modulators.

Curr Pharm Des. 2001 Nov;7(16):1669-87. doi: 10.2174/1381612013397230.

Cyclin-dependent kinase inhibitors for the treatment of chronic lymphocytic leukemia.

Semin Oncol. 2016 Apr;43(2):265-73. doi: 10.1053/j.seminoncol.2016.02.003. Epub 2016 Feb 8.

Targeting cyclin-dependent kinases in anti-neoplastic therapy.

Curr Opin Cell Biol. 2013 Dec;25(6):772-9. doi: 10.1016/j.ceb.2013.08.004. Epub 2013 Sep 6.

引用本文的文献

Transcriptional activation of CBFβ by CDK11 is necessary to promote osteosarcoma cell proliferation.

Cell Commun Signal. 2019 Oct 14;17(1):125. doi: 10.1186/s12964-019-0440-5.

Accumulated cytotoxicity of CDK inhibitor dinaciclib with first-line chemotherapy drugs in salivary adenoid cystic carcinoma cells.

Odontology. 2020 Apr;108(2):300-311. doi: 10.1007/s10266-019-00451-5. Epub 2019 Sep 16.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Opinion Paper: Targeting Multiple Cyclin-Dependent Kinases (CDKs): A New Strategy for Molecular Docking Studies.

作者信息

de Azevedo Walter Filgueira

机构信息

Faculty of Biosciences, Pontifical Catholic University of Rio Grande do Sul. Av. Ipiranga, 6681, Porto Alegre-RS, 90690-900 Brazil.

出版信息

Curr Drug Targets. 2016;17(1):2. doi: 10.2174/138945011701151217100907.

DOI:10.2174/138945011701151217100907

PMID:26687602

Abstract

摘要

相似文献

Opinion Paper: Targeting Multiple Cyclin-Dependent Kinases (CDKs): A New Strategy for Molecular Docking Studies.

Curr Drug Targets. 2016;17(1):2. doi: 10.2174/138945011701151217100907.

Targeting Cyclin-Dependent Kinases and Cell Cycle Progression in Human Cancers.

Semin Oncol. 2015 Dec;42(6):788-800. doi: 10.1053/j.seminoncol.2015.09.024. Epub 2015 Sep 24.

The roles and therapeutic potential of cyclin-dependent kinases (CDKs) in sarcoma.

Cancer Metastasis Rev. 2016 Jun;35(2):151-63. doi: 10.1007/s10555-015-9601-1.

Recent advances on CDK inhibitors: An insight by means of in silico methods.

Eur J Med Chem. 2017 Dec 15;142:300-315. doi: 10.1016/j.ejmech.2017.07.067. Epub 2017 Aug 4.

The anticancer activity of the substituted pyridone-annelated isoindigo (5'-Cl) involves G0/G1 cell cycle arrest and inactivation of CDKs in the promyelocytic leukemia cell line HL-60.

Cell Physiol Biochem. 2015;35(5):1943-57. doi: 10.1159/000374003. Epub 2015 Mar 27.

Clinical anticancer drug development: targeting the cyclin-dependent kinases.

Br J Cancer. 2005 Jan 17;92(1):7-12. doi: 10.1038/sj.bjc.6602229.

Tetrahydro-3H-pyrazolo[4,3-a]phenanthridine-based CDK inhibitor.

Chem Commun (Camb). 2018 May 1;54(36):4521-4524. doi: 10.1039/c8cc01154k.

Early development of cyclin dependent kinase modulators.

Curr Pharm Des. 2001 Nov;7(16):1669-87. doi: 10.2174/1381612013397230.

Cyclin-dependent kinase inhibitors for the treatment of chronic lymphocytic leukemia.

Semin Oncol. 2016 Apr;43(2):265-73. doi: 10.1053/j.seminoncol.2016.02.003. Epub 2016 Feb 8.

Targeting cyclin-dependent kinases in anti-neoplastic therapy.

Curr Opin Cell Biol. 2013 Dec;25(6):772-9. doi: 10.1016/j.ceb.2013.08.004. Epub 2013 Sep 6.

引用本文的文献

Transcriptional activation of CBFβ by CDK11 is necessary to promote osteosarcoma cell proliferation.

Cell Commun Signal. 2019 Oct 14;17(1):125. doi: 10.1186/s12964-019-0440-5.

Accumulated cytotoxicity of CDK inhibitor dinaciclib with first-line chemotherapy drugs in salivary adenoid cystic carcinoma cells.

Odontology. 2020 Apr;108(2):300-311. doi: 10.1007/s10266-019-00451-5. Epub 2019 Sep 16.

Opinion Paper: Targeting Multiple Cyclin-Dependent Kinases (CDKs): A New Strategy for Molecular Docking Studies.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

Opinion Paper: Targeting Multiple Cyclin-Dependent Kinases (CDKs): A New Strategy for Molecular Docking Studies.

作者信息

机构信息

出版信息

相似文献

引用本文的文献